Medical Marijuana, Inc. (MJNA)

0.04
0.00 2.78
OTC
Prev Close 0.04
Open 0.04
Day Low/High 0.04 / 0.05
52 Wk Low/High 0.04 / 0.12
Volume 7.12M
Exchange OTC
Shares Outstanding 3653.59B
Market Cap 168.07M
Div & Yield N.A. (N.A)

Latest News

HempMeds®, Subsidiary Of Medical Marijuana, Inc., Announces Launch Of New CBD Pet Product Line At SuperZoo 2019

HempMeds®, Subsidiary Of Medical Marijuana, Inc., Announces Launch Of New CBD Pet Product Line At SuperZoo 2019

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ --  Medical Marijuana, Inc .

Medical Marijuana, Inc. Announces Second Quarter Filing Date And Schedules Investor Conference Call For August 15, 2019

Medical Marijuana, Inc. Announces Second Quarter Filing Date And Schedules Investor Conference Call For August 15, 2019

SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc .

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch Of Watermelon-Flavored CBD Gummies

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Launch Of Watermelon-Flavored CBD Gummies

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ --  Medical Marijuana, Inc .

Medical Marijuana, Inc. Subsidiary Kannaway® Grows International Leadership Team With Janne Heimonen As Managing Director Of European Division

Medical Marijuana, Inc. Subsidiary Kannaway® Grows International Leadership Team With Janne Heimonen As Managing Director Of European Division

SAN DIEGO, July 17, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Updated Branding Strategy And Website To Expand Consumer Reach

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Updated Branding Strategy And Website To Expand Consumer Reach

- Consumer demand for hemp-derived cannabidiol (CBD) products has increased as Kannaway® saw a 130 percent increase in sales revenue for Q1 of 2019 when compared to Q1 2018

Medical Marijuana, Inc. And Subsidiaries Kannaway® And HempMeds® Announce June 2019 As The Largest Sales Bookings Month In Company History

Medical Marijuana, Inc. And Subsidiaries Kannaway® And HempMeds® Announce June 2019 As The Largest Sales Bookings Month In Company History

- Medical Marijuana, Inc. completed the first-ever high-level stability study on a cannabidiol (CBD) hemp oil product

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Industrial Hemp Association Membership

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Industrial Hemp Association Membership

- Europe's cannabidiol (CBD) market is expected to grow over 400 percent by 2023

Medical Marijuana, Inc. Issues Letter To Shareholders

Medical Marijuana, Inc. Issues Letter To Shareholders

SAN DIEGO, June 27, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner

Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc.'s Cannabinoid Oral Care Products Registered For Use In Clinical Trials Through Australian Healthcare Partner

NEW YORK, June 26, 2019 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Dixie Botanicals®, Subsidiary Of Medical Marijuana, Inc., Announces Partnership With Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen

Dixie Botanicals®, Subsidiary Of Medical Marijuana, Inc., Announces Partnership With Surface Products Corp. To Sell Fitness-Focused CBD-Infused Sunscreen

- The global cannabidiol (CBD) skin care market is expected to reach $384.9 million by 2024

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series Of Cannabinoid Medicine Courses In São Paulo

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Announces Third Series Of Cannabinoid Medicine Courses In São Paulo

- The company's Brazilian subsidiary is launching its third series of courses to teach doctors about cannabinoids, the endocannabinoid system and potential therapeutic uses of cannabidiol (CBD) in Brazil

Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward On Oral Healthcare Line With Cannabinoid Product Supply Agreement

Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward On Oral Healthcare Line With Cannabinoid Product Supply Agreement

SAN DIEGO, June 13, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC:MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Announces Completion Of The First-Ever High-Level Stability Study On A CBD Hemp Oil Product

Medical Marijuana, Inc. Announces Completion Of The First-Ever High-Level Stability Study On A CBD Hemp Oil Product

SAN DIEGO, June 12,  2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Subsidiary HempMeds® Adds New CBD-Infused Products To Personal Care Line

Medical Marijuana, Inc. Subsidiary HempMeds® Adds New CBD-Infused Products To Personal Care Line

SAN DIEGO, June 5, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Subsidiary Kannaway® Expands International Leadership Team With Peter Dale As General Manager Of Japan Division

Medical Marijuana, Inc. Subsidiary Kannaway® Expands International Leadership Team With Peter Dale As General Manager Of Japan Division

SAN DIEGO, June 4, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, today...

Medical Marijuana, Inc. Announces International Coverage At FDA Public Hearing On Cannabis And CBD Products

Medical Marijuana, Inc. Announces International Coverage At FDA Public Hearing On Cannabis And CBD Products

SAN DIEGO, June 3, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Everyday Wellness Functional CBD Solutions Product Line

Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Everyday Wellness Functional CBD Solutions Product Line

SAN DIEGO, May 30, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. CEO To Present On CBD Safety At Sixth Annual New York Cannabis World Congress; Subsidiary HempMeds® To Exhibit New CBD Products

Medical Marijuana, Inc. CEO To Present On CBD Safety At Sixth Annual New York Cannabis World Congress; Subsidiary HempMeds® To Exhibit New CBD Products

SAN DIEGO , May 29, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever Authorization In Bulgaria To Sell Hemp-Derived CBD Products

Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever Authorization In Bulgaria To Sell Hemp-Derived CBD Products

SAN DIEGO, May 28, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research On CBD And Chemotherapy-Induced Peripheral Neuropathy

Medical Marijuana, Inc. Portfolio Company Kannalife, Inc. Publishes New Research On CBD And Chemotherapy-Induced Peripheral Neuropathy

SAN DIEGO, May 23, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and...

Medical Marijuana, Inc. CEO Chosen To Present Oral Comments At FDA's Public Hearing On Products Containing Cannabis And Cannabis-Derived Compounds

Medical Marijuana, Inc. CEO Chosen To Present Oral Comments At FDA's Public Hearing On Products Containing Cannabis And Cannabis-Derived Compounds

SAN DIEGO, May 21, 2019 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that the Company's CEO, Dr.

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Launches New Natural Orange-Flavored CBD Tincture

SAN DIEGO, May 15, 2019 /PRNewswire/ --  Medical Marijuana, Inc . (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary  Dixie Botanicals® has released a new orange-flavored cannabidiol (CBD)...

Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent For Cannabis Gum As A Treatment For Migraine Symptoms

Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent For Cannabis Gum As A Treatment For Migraine Symptoms

NEW YORK, May 14, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company's major investment company AXIM® Biotechnologies, Inc.

Medical Marijuana, Inc. Announces April 2019 As The Largest Sales Bookings Month In Company History

Medical Marijuana, Inc. Announces April 2019 As The Largest Sales Bookings Month In Company History

SAN DIEGO, May 9, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the company had its the largest-ever (unaudited) sales bookings month in its history in...

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee And Tea Pods

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New CBD Coffee And Tea Pods

SAN DIEGO, May 7, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released its new Single-Serving Coffee and Tea Pods,...

Medical Marijuana, Inc. Subsidiary Kannaway® Honored As Gold Stevie® Award Winner In 2019 American Business Awards®

Medical Marijuana, Inc. Subsidiary Kannaway® Honored As Gold Stevie® Award Winner In 2019 American Business Awards®

SAN DIEGO, May 2, 2019 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, was named the winner of a Gold Stevie® Award in...